Abiopharma

News list

Korman Tyler Paz 🟡 adjusted position in 0 shares (1 derivative) of EXOZYMES INC. (EXOZ) Transaction Date: Aug 19, 2026 | Filing ID: 040116

Full text

News bot Aug. 25, 2026, 10:58 p.m.
🔍 Korman Tyler Paz (Executive)

Company: EXOZYMES INC. (EXOZ)

Report Date: 2026-08-19
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 32,964
- Total shares sold: 32,964
Detailed Transactions and Holdings:
- Acquired 32,964 shares of Common Stock (Direct)
  Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | shares_owned_after: 762,837.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 32,964 shares of Restricted Stock Unit (Derivative)
  Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | shares_owned_after: 46,140.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: The RSU convert on a one-for-one basis.
- F2: On March 28, 2022, and May 1, 2023, the reporting person was granted an aggregate of 79,104 RSUs, vesting periodically. The first vesting was August 19, 2026, in the amount of 32,964 shares of common stock.